Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
97.6%
-
Total 13F principal
-
$373,094,912
-
Principal change
-
+$202,006,912
-
Total reported market value
-
$366,446,586
-
Number of holders
-
35
-
Value change
-
+$199,449,681
-
Number of buys
-
30
-
Number of sells
-
5
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q2 2019
As of 30 Jun 2019,
SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 was held by
35 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$373,094,912
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, PRUDENTIAL PLC, NN Investment Partners Holdings N.V., JPMORGAN CHASE & CO, ZAZOVE ASSOCIATES LLC, CALAMOS ADVISORS LLC, MACKAY SHIELDS LLC, STATE STREET CORP, and Invesco Ltd..
This page lists
35
institutional bondholders reporting positions
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.